Results

Total Results: 1,265 records

Showing results for "participants".

21. Archived: Evidence Summary: Latent Tuberculosis Infection: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-latent-tuberculosis/latent-tuberculosis-infection-screening-september-2016
    September 06, 2016 - ), or the vast majority of participants (more than 75%) were TST positive. … Pooled Estimate (95% CI) I 2 , % No. of Studies Participants, No. … TB (for sensitivity) and healthy, low-risk participants (for specificity). … TB (for sensitivity) and healthy, low-risk participants (for specificity). … b Unique participants analyzed to generate estimates of sensitivity or specificity.

22. Draft Recommendation: Eating Disorders in Adolescents and Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/screening-eating-disorders-adolescents-adults
    October 19, 2021 - No trials were found that enrolled participants who were screen-detected in primary care. … Many enrolled participants via advertisements for interventions for binge eating and obesity. … ); pooled estimates for unguided self-help (6 trials; n=368 participants) also favored the intervention … ) and unguided self-help (pooled SMD, 0.37 [95% CI, -0.68 to -0.05]; 3 trials; n=156 participants). … Trials mostly recruited participants with advertisements for binge eating and obesity.

23. Final Recommendation Statement: Obstructive Sleep Apnea in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/obstructive-sleep-apnea-in-adults-screening
    November 15, 2022 - Study sizes ranged from 43 to 1033 participants, and studies were generally conducted in participants … All studies recruited participants with known or suspected OSA from specialty clinics. … In 7 trials, 17% to 74% of participants reported oral mucosal, dental, or jaw symptoms, compared with … In 4 trials, 5% to 33% of participants reported oral dryness, compared with 0% to 3% in control groups … , and in 3 trials, 23% to 68% of participants reported excessive salivation, compared with 0% to 3% in

24. Archived: Final Evidence Summary: Skin Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary46/skin-cancer-screening-2009
    February 15, 2009 - , comorbid conditions, sun exposures, demographics of case patients and control participants, definition … Control participants ( n = 549) were identified from the general public through random-digit dialing … Participants were followed biannually for a mean of 5.4 years. … The response rate for case patients and control participants was 75% and 70%, respectively. … This study of 639,835 participants who were screened during the American Academy of Dermatology Skin

25. Screening for Vitamin D Deficiency in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/XCAMvXugbjnYnGmeF5GtUS
    April 13, 2021 - Treatment was limited to studies enrolling or analyzing participants with low serum vitamin D levels. … The pooled ARD for incidence of participants with 1 or more falls was −4.3% (95% CI, −11.6% to 2.9%; … Nine studies17,18,21,22,35,36,43,52,57 enrolled participants with se- rum vitamin D levels less than … Lips et al (2010)43 included a majority of participants who were community-dwelling participants; thus … Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL).

26. Final Evidence Summary: Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/bacterial-vaginosis-in-pregnancy-to-prevent-preterm-delivery-screening
    April 07, 2020 - Participants were not required to be pregnant in studies selected for KQ2. … for the subgroup of participants testing positive for bacterial vaginosis at study entry. … with a prior preterm delivery ( Figure 4 ). 54 , 57 In Morales et al (n = 80), 54 4 participants ( … 11%) in the placebo group and 2 participants (4.6%) in the oral metronidazole group had a spontaneous … w OIS study included 155,504 participants; 58 the other study included 199,451 participants; 59 3

27. Archived: Evidence Summary: Alcohol Misuse: Screening and Behavioral Counseling Interventions in Primary Care | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary9/alcohol-misuse-screening-and-behavioral-counseling-interventions-in-primary-care
    September 25, 2012 - and exclusion criteria to substantially limit the number of such participants. … Control participants generally reduced alcohol consumption. … Moderate 12% fewer participants reported heavy drinking episodes (CI, 7%–16%); 7 trials; 2737 participants … Moderate Achieved by 11% more participants (CI, 8%–13%); 9 trials; 5973 participants Moderate … - Insufficient Achieved by 9% more participants (CI, 2%–16%); 2 trials, 776 participants Low

28. Archived: Evidence Summary: Alcohol Misuse: Screening and Behavioral Counseling Interventions in Primary Care | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary9/alcohol-misuse-screening-and-behavioral-counseling-interventions-in-primary-care-2013
    September 25, 2012 - and exclusion criteria to substantially limit the number of such participants. … Control participants generally reduced alcohol consumption. … Moderate 12% fewer participants reported heavy drinking episodes (CI, 7%–16%); 7 trials; 2737 participants … Moderate Achieved by 11% more participants (CI, 8%–13%); 9 trials; 5973 participants Moderate … - Insufficient Achieved by 9% more participants (CI, 2%–16%); 2 trials, 776 participants Low

29. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary27/breast-cancer-medications-for-risk-reduction-2013
    April 15, 2013 - age, 51 y) Derivation: 2569 case participants with 2588 control participants Validation: 2700 … participants taking tamoxifen, 2708 participants taking placebo Derivation: case–control Validation … to missing data; 2873 for subgroup analysis; 2412 ER+ case participants; 461 ER− case participants; … eligible case participants and 83% of eligible control participants; follow-up through 1998 243,221 … , 2588 control participants Validation: 10,083 participants Derivation: case–control Validation

30. Evidence Summary: Atrial Fibrillation: Screening With Electrocardiography | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/atrial-fibrillation-screening-with-electrocardiography
    August 07, 2018 - Participants in treatment trials were not screen detected, and most had long-standing persistent atrial … An analysis of 2595 participants in the SAFE study from 49 general practices assessed the accuracy of … No trials or systematic reviews that focused on asymptomatic, screen-detected participants were found … The mean age of participants in trials evaluating warfarin ranged from 67 to 74 years. … Four trials enrolled fewer than 30% women and just 1 reported race or ethnicity (16% of participants

31. Final Evidence Review: Glaucoma: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review38/glaucoma-screening
    February 15, 2013 - Data Extraction:  Two investigators abstracted or checked information about study design, participants … in participants receiving trabeculectomy (CI, 1.4 to 3). … in participants receiving medical treatment (CI, 4.3 to 8.0; 2 RCTs). … participants receiving levobunolol (CI, 1.2- to 4.1-fold). … Participants using brimonidine had an increased risk for fatigue.

32. Archived: Final Evidence Review: Glaucoma: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review38/glaucoma-screening-2013
    February 15, 2013 - Data Extraction:  Two investigators abstracted or checked information about study design, participants … in participants receiving trabeculectomy (CI, 1.4 to 3). … in participants receiving medical treatment (CI, 4.3 to 8.0; 2 RCTs). … participants receiving levobunolol (CI, 1.2- to 4.1-fold). … Participants using brimonidine had an increased risk for fatigue.

33. Archived: Evidence Summary: Atrial Fibrillation: Screening With Electrocardiography | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/atrial-fibrillation-screening-with-electrocardiography-august-2018
    August 07, 2018 - Participants in treatment trials were not screen detected, and most had long-standing persistent atrial … An analysis of 2595 participants in the SAFE study from 49 general practices assessed the accuracy of … No trials or systematic reviews that focused on asymptomatic, screen-detected participants were found … The mean age of participants in trials evaluating warfarin ranged from 67 to 74 years. … Four trials enrolled fewer than 30% women and just 1 reported race or ethnicity (16% of participants

34. Evidence Summary: Latent Tuberculosis Infection in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/latent-tuberculosis-infection-screening
    May 02, 2023 - A total of 112 studies (113 articles) with 69,009 participants were included. … The second RCT was an open-label, multinational trial that randomized 6063 participants at increased … The second RCT was an open-label multicenter trial that randomized 283 participants to either 3 months … That study was an open-label trial that randomized 52 participants with LTBI. 133 A single open-label … ); 11 studies (939 participants); specificity, 0.98 (95% CI, 0.95-0.99); 1 study (211 participants)

35. Draft Recommendation: Obstructive Sleep Apnea in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/obstructive-sleep-apnea-adults-screening
    March 29, 2022 - Study sizes ranged from 43 to 1,033 and studies were generally conducted in participants with underlying … Most trials enrolled participants from sleep clinics and no trial enrolled screen-detected populations … All studies recruited participants with known or suspected OSA from specialty clinics. … Overall, 1% to 47% of trial participants reported any harms from treatment with PAP, including oral or … , and in three trials, 23% to 68% of participants reported excessive salivation compared with 0% to 3%

36. Evidence Summary: Atrial Fibrillation: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/atrial-fibrillation-screening
    January 25, 2022 - Most study participants had long-standing, persistent AF; few had a history of transient ischemic attack … ), major bleeding events occurred in 20 participants from the warfarin groups and 11 participants from … who received ECG screening and participants whose clinicians received pulse palpation reminders, but … a direct comparison of screened with not screened participants was not reported. … to anxiety outcomes was unclear. k Includes 1738 participants who were also part of the mSToPS RCT

37. Archived: Final Evidence Summary: Menopausal Hormone Therapy: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary36/menopausal-hormone-therapy-preventive-medication-2012
    May 29, 2012 - Data Extraction: Investigators extracted data on participants, study design, analysis, follow-up, and … Approximately 78% of participants agreed to continue follow-up for a total of 10.7 years 18 , 34 . … Few trials met our inclusion criteria, although the number of participants was large. … * Decreased risk for breast cancer among participants in the WHI estrogen-only trial. … ‡ Increased risk for breast cancer among participants in the WHI estrogen-only trial.

38. Evidence Summary: Lung Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary4/lung-cancer-screening
    July 30, 2013 - A total of 2052 participants were randomly assigned to LDCT and 2052 to usual care. … Among 285 participants with nodules 15 mm or larger, 29.8% were diagnosed with lung cancer 89 . … compared with 3180 for minimally eligible NLST participants 90 . … Baseline characteristics of participants in the randomized national lung screening trial. … ‡ All participants had baseline chest radiography.

39. Archived: Evidence Summary: Lung Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary4/lung-cancer-screening-december-2013
    July 30, 2013 - Data Extraction: One reviewer extracted study data about participants, design, analysis, follow-up, … A total of 2052 participants were randomly assigned to LDCT and 2052 to usual care. … compared with 3180 for minimally eligible NLST participants 90 . … Baseline characteristics of participants in the randomized national lung screening trial. … ‡ All participants had baseline chest radiography.

40. Screening for Skin Cancer: An Update of the Evidence (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/LgBN7_z7hqynt6BRzUUYA-
    February 01, 2009 - Control participants (n � 549) were identified from the general public through random-digit dialing … The response rate for case patients and control participants was 75% and 70%, respectively. … However, the researchers did not follow the participants with negative results, and therefore could … We found no RCTs that compared screened and un­ screened participants with respect to thickness of mela … This study of 639 835 participants who were 3 February 2009 Annals of Internal Medicine Volume 150